- JP-listed companies
- ADR120S, Inc.
- Balance sheet
ADR120S, Inc. (3750) Balance sheet
Market cap
¥7.1B
P/E ratio
357.9x
Saitori Cell Research Institute develops regenerative cell therapies and medical devices while also investing in real estate projects through seven subsidiaries.
| 2014/03 | 2015/03 | 2016/03 | 2017/03 | 2018/03 | 2019/03 | 2020/03 | 2021/03 | 2022/03 | 2023/03 | 2024/03 | 2025/03 | 2026/03 | |
| Cash and cash equivalents | - | 1,127 | 840 | 2,325 | 996 | 1,533 | 1,000 | 1,070 | 852 | 1,123 | 1,038 | 256 | 126 |
| Inventories | - | 101 | 90 | 35 | - | - | - | - | - | - | - | - | - |
| Total current assets | - | 4,459 | 3,834 | 2,801 | 3,128 | 7,256 | 6,480 | 6,270 | 3,029 | 1,388 | 1,428 | 517 | 351 |
| Property, plant and equipment, net | - | 168 | 11 | 6 | 2,218 | 6 | 7,662 | 7,467 | 12,041 | 11,727 | 4,218 | 2,960 | - |
| Marketable securities, non-current | - | - | - | - | - | 200 | 369 | 314 | - | - | - | - | 10 |
| Total non-current assets | - | 262 | 72 | 41 | 2,245 | 229 | 9,003 | 8,654 | 12,978 | 12,703 | 4,389 | 3,020 | 18 |
| Total assets | - | 4,721 | 3,906 | 2,841 | 5,374 | 7,485 | 15,483 | 14,924 | 16,007 | 14,092 | 5,816 | 3,538 | 368 |
| Accounts payable | - | 366 | 296 | - | - | - | - | - | - | - | - | - | - |
| Short-term debt | - | 282 | 218 | - | 2,200 | 280 | 27 | - | 164 | 500 | 70 | 300 | - |
| Long-term debt, current | - | - | - | - | - | 110 | 521 | 521 | 553 | 401 | 55 | 54 | - |
| Total current liabilities | - | 1,507 | 674 | 120 | 2,256 | 886 | 813 | 735 | 995 | 1,174 | 536 | 492 | 227 |
| Total non-current liabilities | - | 21 | 6 | 5 | 43 | 2,999 | 10,837 | 10,641 | 11,295 | 10,261 | 2,485 | 2,415 | 119 |
| Total liabilities | - | 1,528 | 680 | 125 | 2,298 | 3,884 | 11,650 | 11,376 | 12,290 | 11,435 | 3,021 | 2,907 | 346 |
| Retained earnings | - | 148 | 182 | -282 | 167 | 1,257 | 1,442 | 543 | 463 | -597 | -459 | -2,619 | -3,015 |
| Stockholders' equity | 3,031 | 3,193 | 3,226 | 2,717 | 3,075 | 3,601 | 3,833 | 3,548 | 3,716 | 2,657 | 2,796 | 631 | 22 |